Innovate4Health: mPedigree Battles Counterfeit Drugs Through Innovative Verification System

This post is one of a series in the #Innovate4Health policy research initiative. Counterfeit medicines sold under a product name without proper authorization are a serious threat to global public health. Classified by the World Health Organization (WHO) as substandard, spurious, falsely labelled, falsified and counterfeit (SSFFC) medical products, counterfeit drugs are regularly designed to … Continue reading “Innovate4Health: mPedigree Battles Counterfeit Drugs Through Innovative Verification System”

Innovate4Health: Eye Exams On-the-Go with PEEK

This post is one of a series in the #Innovate4Health policy research initiative. Hundreds of millions of people worldwide have vision problems that could be fixed or relieved if only they were diagnosed early enough. Unfortunately, current eye screening equipment is expensive, bulky, and requires specialists to operate it. As a result, the vast majority … Continue reading “Innovate4Health: Eye Exams On-the-Go with PEEK”

Innovate4Health: Global Good’s “Arktek”: A Life-Saving Super-Thermos Vaccine Cooler

This post is one of a series in the #Innovate4Health policy research initiative. More than 1.5 million children die every year from diseases that existing vaccines could prevent. Why aren’t these children vaccinated? One big reason is that vaccines need to be kept cool until they reach patients, but that’s a really hard task in … Continue reading “Innovate4Health: Global Good’s “Arktek”: A Life-Saving Super-Thermos Vaccine Cooler”

How IP Helps Individuals

This is the second in a series of posts summarizing CPIP’s 2016 Fall Conference, “Intellectual Property and Global Prosperity.” The Conference was held at Antonin Scalia Law School, George Mason University on October 6-7, 2016. Videos of the conference panels and keynote address, as well as other materials, are available on the conference website. The … Continue reading “How IP Helps Individuals”

Intellectual Property Backgrounds of President Trump’s Potential Supreme Court Nominees

By Andrew Baluch[1] & Devlin Hartline President Donald Trump will soon announce his nominee to fill the vacancy left at the Supreme Court by late Associate Justice Antonin Scalia. On September 23, 2016, the Trump campaign revealed that there are twenty-one candidates under consideration for the nomination. Below is a summary of the intellectual property … Continue reading “Intellectual Property Backgrounds of President Trump’s Potential Supreme Court Nominees”

Creative Upstarts and Startups: How IP Creates Opportunities and Opens Doors

This is the first in a series of posts summarizing CPIP’s 2016 Fall Conference, “Intellectual Property & Global Prosperity.“ The conference was held at Antonin Scalia Law School, George Mason University on October 6-7, 2016. Videos of the conference panels and keynote address, as well as other materials, are available on the conference website. The … Continue reading “Creative Upstarts and Startups: How IP Creates Opportunities and Opens Doors”

New CPIP Report: The Global Patent Pendency Problem

Why are some of the biggest fights about patent policy almost pointless in some places? Because in many countries, including some of the world’s most important emerging economies, it takes so long to get patents that the rights have little meaning. The Center for the Protection of Intellectual Property (CPIP) released a report today entitled The Long … Continue reading “New CPIP Report: The Global Patent Pendency Problem”

Law Professors & Economists Urge Caution on VENUE Act in Letter to Congress

Today, 28 law professors, economists, and political scientists from across the nation submitted a letter to Congress expressing serious concerns about the recent push for sweeping changes to patent litigation venue rules, such as those proposed in the VENUE Act. The letter is copied below, and it can be downloaded here: http://ssrn.com/abstract=2816062 Although proponents for … Continue reading “Law Professors & Economists Urge Caution on VENUE Act in Letter to Congress”

Federal Circuit Brings Some Clarity and Sanity Back to Patent Eligibility Doctrine

By Adam Mossoff and Kevin Madigan Following the Supreme Court’s four decisions on patent eligibility for inventions under § 101 of the Patent Act, there has been much disruption and uncertainty in the patent system. The patent bar and most stakeholders in the innovation industries have found the Supreme Court’s decisions in Alice Corp. v. … Continue reading “Federal Circuit Brings Some Clarity and Sanity Back to Patent Eligibility Doctrine”

Do As I Say, Not As I Do: Google’s Patent Transparency Hypocrisy

It is common today to hear that it’s simply impossible to search a field of technology to determine whether patents are valid or if there’s even freedom to operate at all. We hear this complaint about the lack of transparency in finding “prior art” in both the patent application process and about existing patents. The … Continue reading “Do As I Say, Not As I Do: Google’s Patent Transparency Hypocrisy”